Author

Osama Elhadi Bakheet

Observed names: Bakheet, Osama Elhadi, OE Bakheet, Osama E Bakheet, Osama E L Hadi Bakheet, Osama EL Hadi Bakheit, Osama El Hadi Bakheet, Osama El Hadi Bakhiet, Osama Elhadi Bakhiet

Institutions: University of Khartoum, Mycetoma Research Center

Observed institutions: University of Khartoum, University of Dongola, Mycetoma Research Center

ORCID: 0000-0002-1565-2795

Observed ORCID: 0000-0002-1565-2795

OpenAlex ID: A5062420214

Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial

2024 · Ahmed H Fahal, Eiman Siddig Ahmed, et al. · The Lancet Infectious Diseases · 35

Mycetoma imaging: the best practice

2020 · Mustafa Elnour Bahar, Osama E L Hadi Bakheet, et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 35

Individual Risk Factors of Mycetoma Occurrence in Eastern Sennar Locality, Sennar State, Sudan: A Case-Control Study

2022 · Rowa Hassan, Kebede Deribe, et al. · Tropical Medicine and Infectious Disease · 22

PDF

Evaluation and Improvement of the Quality of Surgical Operative Notes in the Department of General Surgery at Dongola Teaching Hospital, Sudan

2024 · Osama Elhadi Bakheet, Abubakr Muhammed, et al. · Cureus · 15

PDF

Staphylococcus aureus causing primary foot botryomycosis mimicking actinomycetoma: a case report from Sudan

2022 · Emmanuel Edwar Siddig, Bertrand Nyuykonge, et al. · International Journal of Infectious Diseases · 13

PDF

Molecular detection of human papillomavirus-16 among Sudanese patients diagnosed with squamous cell carcinoma and salivary gland carcinoma

2021 · Fatima E. Mohamed, Leena N. Aldayem, et al. · BMC Research Notes · 13

PDF

Multiple extensive Madurella mycetomatis eumycetoma lesions: a case report and review of the literature

2020 · Dania M Zaid, Osama E Bakheet, et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 11

S4.5a A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surgery, in patients with eumycetoma in Sudan—top line results

2022 · Ahmed Hassan Fahal, Sahar Mubarak Bakhiet, et al. · Medical Mycology · 3

Association of interleukin-17A rs2275913 polymorphism with rheumatoid arthritis susceptibility in Sudanese population

2021 · Rgda Mohamed Osman, Mounkaila Noma, et al. · SAGE Open Medicine · 3

Extensive perineal Actinomadura pelletieri actinomycetoma-induced urethral stricture: a rare complication

2020 · Osama Elhadi Bakheet, Muawia Ahmed Hassan, et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 3

Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole, and Hydroxyitraconazole in Sudanese Patients With Eumycetoma

2025 · Wan-Yu Chu, Ahmed H Fahal, et al. · The Journal of Infectious Diseases · 2

PDF

Once-weekly repurposed fosravuconazole versus daily itraconazole, with surgery, in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial

2024 · AH Fahal, ES Ahmed, et al.

PDF

Once-weekly repurposed fosravuconazole versus daily itraconazole, with surgery, in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial

2024 · AH Fahal, ES Ahmed, et al.

PDF

Works count: 14

Citation count: 155

H-index: 7

I10-index: 7